MODYLUS Trademark

Trademark Overview

On Wednesday, May 15, 2019, a trademark application was filed for MODYLUS with the United States Patent and Trademark Office. The USPTO has given the MODYLUS trademark a serial number of 79263074. The federal status of this trademark filing is REGISTERED as of Tuesday, February 25, 2020. This trademark is owned by Novartis AG. The MODYLUS trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery devices, namely, injection devices for pharmaceuticals, injection devices for administering drugs
modylus

General Information

Serial Number79263074
Word MarkMODYLUS
Filing DateWednesday, May 15, 2019
Status700 - REGISTERED
Status DateTuesday, February 25, 2020
Registration Number5993262
Registration DateTuesday, February 25, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements

Translation of Words in MarkThe wording "MODYLUS" has no meaning in a foreign language.
Goods and ServicesDrug delivery devices, namely, injection devices for pharmaceuticals, injection devices for administering drugs

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, July 19, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Friday, July 17, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 25, 2020FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 25, 2020FINAL DISPOSITION PROCESSED
Monday, May 25, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 25, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 30, 2019ASSIGNED TO LIE
Thursday, October 24, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 6, 2019REFUSAL PROCESSED BY IB
Tuesday, August 20, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 19, 2019REFUSAL PROCESSED BY MPU
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 27, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, July 26, 2019NON-FINAL ACTION WRITTEN
Thursday, July 25, 2019ASSIGNED TO EXAMINER
Tuesday, July 23, 2019APPLICATION FILING RECEIPT MAILED
Friday, July 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 18, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

modylus devices injection administering pharmaceuticals drugs namely delivery drug